IntrepidiaBio

IntrepidaBio is a preclinical biotechnology company dedicated to developing cures for cancer and other diseases through drugs that alter the body’s first line of defense, innate immunity.


Website

intrepidabio.com

Partner

Nina Kjellson

Investment

Series A